High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis

New England Journal of Medicine

Volumn 336, Issue 18, 1997, Pages 1283-1289

  Fitzsimmons, Stacey C ^a   Burkhart, Greg A ^b   Borowitz, Drucy ^c   Grand, Richard J ^d   Hammerstrom, Thomas ^b   Durie, Peter R ^e   Lloyd Still, John D ^f   Lowenfels, Albert B ^g,h  

^a CYSTIC FIBROSIS FOUNDATION   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c CHILDREN S HOSPITAL OF BUFFALO   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f RUSH MEDICAL COLLEGE   (United States)

^g NEW YORK MEDICAL COLLEGE   (United States)

^h EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DONNAZYME; DORNASE ALFA; EUDRAGIT; HISTAMINE H2 RECEPTOR ANTAGONIST; KREON; NUTRIZYME; PANCREAS ENZYME; PANCRELIPASE; TRIACYLGLYCEROL LIPASE; ULTRASE MT; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLON DISEASE; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG FORMULATION; FEMALE; FIBROSIS; HUMAN; INTESTINE ABSORPTION; MALABSORPTION; MALE; ORAL DRUG ADMINISTRATION; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLON; COLONIC DISEASES; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROSIS; HUMANS; INFANT; LIPASE; LOGISTIC MODELS; MALE; ODDS RATIO; PANCREATIC EXTRACTS;

EID: 0030905117     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705013361803     Document Type: Article

References (21)

1. Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet l994;343:85-6.
2. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet 1994;343:109-10.
3. Mahony MJ, Corcoran M. High-strength pancreatic enzymes. Lancet 1994;343:599-600.
4. Briars GL, Griffiths DM, Moore IE, Williams PH, Johnson K, Rollos CJ. High-strength pancreatic enzymes. Lancet 1994;343:600.
5. Knabe N, Zak M, Hansen A, et al. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:1230.
6. Schwarzenberg SJ, Wielinski CL, Shamieh I, et al. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995;127:565-70.
7. Freiman JP, FitzSimmons SC. Colonic strictures in patients with cystic flbrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr 1996;22:153-6.
8. Prestridge L, Rogers BB, Pritchard M, et al. Diffuse fibrosis of the colon complicating cystic fibrosis, J Pediatr Gastroenterol Nutr 1996;22:219- 24.
9. Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy. J Pediatr 1994; 125:587-9.
10. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
11. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995;346:1247-51.
12. Lebenthal E. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better." J Pediatr Gastroenterol Nutr 1994;18:423-5.
13. van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72:Suppl 2:39-48.
14. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
15. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995;346:499-500.
16. Taylor CJ, Steiner GM. Fibrosing colonopathy in a child on low-dose pancreatin. Lancet 1995;346:1106-7.
17. Zerin JM, Kuhn-Fulton J, White SJ, et al. Colonic strictures in children with cystic fibrosis. Radiology 1995;194:223-6.
18. Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 1995;127:681-4.
19. Mac Sweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995;345:752-6.
20. Lloyd-Still JD. Cystic fibrosis and colonic strictures: a new "iatrogenic" disease. J Clin Gastroenterol 1995;21:2-5.
21. Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet 1995;346: 1265-7.